Clinical Trials Logo

Ischemia, Cerebral clinical trials

View clinical trials related to Ischemia, Cerebral.

Filter by:
  • None
  • Page 1

NCT ID: NCT03919370 Recruiting - Surgery Clinical Trials

Detection of Cerebral Ischemia With Artificial Intelligence.

CIDAI-BAS
Start date: October 1, 2020
Phase:
Study type: Observational

In patients undergoing planned surgery for carotid tromendarterendectomy, a non-invasive device that registers heart rate variability is attached. Furthermore a non-invasive device that monitors cerebral oxygenation- near infrared spectroscopy as well as electroencephalography is also attached. At times when surgeons clamps the carotid artery, there will be a moment with controlled cerebral ischemia. This will be registered by the devices. The information obtained will be used to teach artificial intelligence what patterns are related to cerebral ischemia. The same procedure will be performed in patients undergoing ocklusive cerebral trombectomy, so the artificial intelligence will learn to recognize cerebral reperfusion.Blood samples will be drawn before and after cerebral ischemia may occur and will be analyzed for neurobiomarkers and cardiac biomarkers. To teach the algorithm patterns from anaesthesia and surgery in patients without pre existing neuronal injury, the same method will be applied to patients undergoing mixed abdominal surgery. This group will provide a better knowledge of neuro biomarker patterns during anesthesia and surgery.

NCT ID: NCT03903601 Not yet recruiting - Vascular Diseases Clinical Trials

Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage

Start date: December 30, 2021
Phase:
Study type: Observational

The primary aim of the current research project is to answer the question, whether plasma trimethylamine N-oxide (TMAO) level may be used as a marker of ischemic changes in the brain. TMAO is associated with endothelial dysfunction, inflammation and oxidative stress. The hypothesis is that circulating TMAO level may predict leukoaraiosis (LA) and/or stroke. Secondary, the investigators would like to examine whether plasma TMAO concentration is related to cognitive impairment and determine whether choline consumption is associated with an incidence of LA severity and dementia.

NCT ID: NCT02989077 Not yet recruiting - Clinical trials for Risk Factor, Cardiovascular

Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Current Management Status

Start date: January 2017
Phase: N/A
Study type: Observational [Patient Registry]

This study will delineate the risk profile of patients with isolated cerebral or coronary ischemia and those with combined disease. The study will also evaluate current management status of those patients and any unmet needs.This aim is proposed to be achieved by studying 3 groups of patients with coronary, cerebral or combined ischemia. Anticipated each group to be 1000 patients.

NCT ID: NCT02976584 Completed - Epilepsy Clinical Trials

Epileptic Potentials During Cardiac Surgery and Association With Postoperative Neurological Outcome

EPOCAS
Start date: July 11, 2016
Phase:
Study type: Observational

Primarily, the investigators want to test the hypothesis that it is possible to detect epileptiform EEG during cardiac surgery under general anesthesia. Furthermore, the investigators will examine if those epileptic potentials coincide, follow or are unrelated to ischemic events detected by EEG or Near-infrared spectroscopy (NIRS). Finally, the investigators will look for independent associations between intraoperative seizures (with or without ischemic events) and postoperative neurological outcome, as well as between intraoperative seizures (with or without ischemic events) and the total amount of TXA given.